glp-1/gip dual agonist lilly GLP-1 use tripled among non-diabetics, reaching $5.8B in 2022 SURPASS-EARLY: Dual GIP/GLP-1 Receptor Agonist

Statin-induced Kruppel-like factor 2 expression in human and mouse T cells reduces inflammatory and pathogenic responses

Therefore, reducing the number of bacteria that produce SCFAs disrupts the balance of metabolites produced by the intestinal microbiota, affecting their impact on the kidneys

Abstract: We demonstrated for the first time that a marine-derived antimicrobial peptide (AMP), Sph_12-38, exhibit high antimicrobial activity against P

Calabrese V, Cornelius C, Dinkova-Kostova AT et al (2010) Cellular stress responses, the hormesis paradigm, and vitagenes: novel targets for therapeutic intervention in neurodegenerative disorders